C. Daly et al., MDR1 RIBOZYME MEDIATED REVERSAL OF THE MULTIDRUG-RESISTANT PHENOTYPE IN HUMAN LUNG-CELL LINES, Cytotechnology, 19(3), 1996, pp. 199-205
An mdr1 hammerhead was introduced into two adriamycin-selected multi-d
rug resistant human lung cell lines both of which over-express p-glyco
protein. Expression of the ribozyme resulted in a decrease in mdr1 mRN
A expression and an increase in drug sensitivity in both cell lines. T
his would suggest that the use of specific ribozymes may represent an
effective and specific approach in order to restore cellular sensitivi
ty towards anti-cancer drugs.